FDA Approved: ALPRAZOLAM — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for alprazolam submitted by Actavis Pharma, Inc., resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Panic Disorder

Drugs mentioned

• Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)